A detailed history of Israel Discount Bank Of New York transactions in Biogen Inc. stock. As of the latest transaction made, Israel Discount Bank Of New York holds 1,241 shares of BIIB stock, worth $215,673. This represents 0.59% of its overall portfolio holdings.

Number of Shares
1,241
Previous 1,623 23.54%
Holding current value
$215,673
Previous $349,000 17.77%
% of portfolio
0.59%
Previous 0.44%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $72,778 - $90,427
-382 Reduced 23.54%
1,241 $287,000
Q1 2024

May 07, 2024

SELL
$212.02 - $267.71 $106,646 - $134,658
-503 Reduced 23.66%
1,623 $349,000
Q4 2023

Feb 05, 2024

SELL
$222.59 - $267.94 $18,697 - $22,506
-84 Reduced 3.8%
2,126 $550,000
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $4,812 - $5,431
19 Added 0.87%
2,210 $567,000
Q2 2023

Jul 25, 2023

SELL
$275.25 - $318.06 $67,986 - $78,560
-247 Reduced 10.13%
2,191 $624,000
Q1 2023

May 04, 2023

SELL
$256.56 - $292.34 $4,874 - $5,554
-19 Reduced 0.77%
2,438 $677,000
Q4 2022

Feb 07, 2023

BUY
$252.44 - $306.72 $105,015 - $127,595
416 Added 20.38%
2,457 $681,000
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $94,424 - $130,203
-485 Reduced 19.2%
2,041 $545,000
Q2 2022

Aug 10, 2022

BUY
$187.54 - $223.02 $473,726 - $563,348
2,526 New
2,526 $515,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $205,558 - $264,172
-918 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$282.99 - $369.05 $259,784 - $338,787
918 New
918 $260,000
Q4 2020

Feb 17, 2021

SELL
$236.26 - $355.63 $167,744 - $252,497
-710 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $187,986 - $217,054
710 New
710 $202,000
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $341,172 - $451,823
-1,319 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $177,441 - $225,086
-660 Reduced 33.35%
1,319 $417,000
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $12,103 - $16,723
55 Added 2.86%
1,979 $588,000
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $4,348 - $4,877
-20 Reduced 1.03%
1,924 $447,000
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $18,420 - $20,304
84 Added 4.52%
1,944 $454,000
Q1 2019

May 08, 2019

BUY
$216.71 - $338.96 $4,117 - $6,440
19 Added 1.03%
1,860 $440,000
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $38,990 - $49,385
-140 Reduced 7.07%
1,841 $554,000
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $114,175 - $149,309
-389 Reduced 16.41%
1,981 $700,000
Q2 2018

Aug 01, 2018

SELL
$257.52 - $306.91 $13,906 - $16,573
-54 Reduced 2.23%
2,370 $688,000
Q1 2018

May 17, 2018

SELL
$260.13 - $367.91 $9,364 - $13,244
-36 Reduced 1.46%
2,424 $664,000
Q4 2017

Feb 13, 2018

SELL
$307.64 - $344.58 $127,670 - $143,000
-415 Reduced 14.43%
2,460 $784,000
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $808,306 - $947,858
2,875
2,875 $900,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Israel Discount Bank Of New York Portfolio

Follow Israel Discount Bank Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Israel Discount Bank Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Israel Discount Bank Of New York with notifications on news.